Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

The combination of the excimer lamp and liquor carbonis detergens is more effective for scalp psoriasis than the lamp alone.

Current SLE classifications need refinement, and the complement system is a key therapeutic target.

PNH can occur in patients with SLE, so doctors should be aware of this.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Men with systemic lupus erythematosus often have more severe symptoms but can respond well to treatment.

People with mycosis fungoides/Sézary syndrome have a much lower quality of life.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

Rhupus is a complex syndrome that combines rheumatoid arthritis and lupus, making diagnosis challenging.

SLE patients often face depression and anxiety due to physical changes, with African-American and Hispanic patients having higher unmet psychological needs.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.